JALEESA ATKINS: Open Payments
NPI 1093332546 · JACKSON, MI. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$754 in 35 payments from 7 companies in 2025. Trend: 2023 $190 · 2024 $851 · 2025 $754
Food & beverage: $754
| Company | Payments | Amount |
|---|---|---|
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 18 | $349 |
| Axsome Therapeutics, Inc. | 5 | $112 |
| E.R. Squibb & Sons, L.L.C. | 2 | $104 |
| Otsuka America Pharmaceutical, Inc. | 4 | $80 |
| ABBVIE INC. | 4 | $79 |
| Lundbeck LLC | 1 | $17 |
| Alkermes, Inc. | 1 | $14 |
Products named: CAPLYTA, Auvelity, COBENFY, VRAYLAR, REXULTI, ABILIFY MAINTENA, ABILIFY ASIMTUFII, ARISTADA.
Industry payments across MI — which companies pay providers there.
